 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Jubilant Pharmo Standalone September 2023 Net Sales at Rs 186.30 crore, down 16.45% Y-o-Y

Jubilant Pharmo Consolidated September 2023 Net Sales at Rs 1,680.30 crore, up 5.05% Y-o-Y

The Cup and Handle Pattern breakout is observed on the daily chart of Indian Railway Catering &amp; Tourism Corporation. Price breakout is accompanied with rising volumes.

Hot Stocks | IRCTC, India Glycols, Jubilant Pharmova may deliver at least 10% return

A significant breakthrough above the 19,500 mark could potentially trigger a rally towards higher levels.

Hot Stocks | Here is why you should bet on Bank of Maharashtra, Jubilant Pharmova, Paytm for short term

Jubilant Pharmova has seen Bullish Engulfing kind of pattern on the daily charts, rising 6 percent to Rs 458, the highest closing level since May 2, 2022 and recouped all its previous two-day losses.

Trade Spotlight | How you should trade in Uno Minda, Jubilant Pharmova, Nazara Tech today

If the index breaks 19,300, then it may get the next support around 19,000, whereas on the higher side, 19,600-19,650 is expected to be a crucial hurdle in the near term, experts said

Top 10 stocks to secure healthy returns as bears gain control over the market

Jubilant Pharmo Consolidated June 2023 Net Sales at Rs 1,586.90 crore, up 9.31% Y-o-Y

Jubilant Pharmo Standalone June 2023 Net Sales at Rs 217.40 crore, up 6.27% Y-o-Y

The company has reported a year-on-year decline in all major financial metrics barring revenue for the recently ended quarter

Jubilant Pharmova slumps 3% on 86% decline in net profit for Q1FY24

Jubilant Pharmo Standalone March 2023 Net Sales at Rs 199.84 crore, up 594.13% Y-o-Y

Jubilant Pharmova Ltd. engages in the provision of basic organic chemicals. It operates through the following segments: Radiopharma, Allergy Immunotherapy, CDMO Sterile Injectables, Contract Research Development and Manufacturing Organisation, Generics, and Proprietary Novel Drugs. The Radiopharma segment is involved in products for diagnosis and treatment of various diseases, including Pulmonary Embolism, Cancer, Coronary Artery Diseaseand many others. The Allergy Immunotherapy segment provides diagnostic devices for skin testing. The CDMO Sterile Injectables segment offer manufacturing services including sterile fill and finish injectables, full-service ophthalmic offer, and ampoules. The Generics segment includes development, manufacturing, distribution, sales and marketing of generics formulations. The CRDMO segment relates to drug discovery and development services. The company was founded on June 21, 1978 and is headquartered in Noida, India.

Watchers	46
52-Wk Low	268.90
52-Wk High	485.10

Market Cap	67.68B
Volume (M)	573,220.00
52-Wk High	485.10
52-Wk Low	268.90

JUBLPHARMA.NSE Jubilant Pharmova Ltd.

About

Feed

News

Sentiment

Fundamentals